Home administration of filgrastim (Nivestim™) in primary prophylaxis of chemotherapy-induced febrile neutropenia

BACKGROUND: The granulocyte-colony stimulating factor (G-CSF) biosimilar filgrastim (Nivestim™) reduces the duration and severity of neutropenia and the frequency of occurrence of febrile neutropenia (FN). Administration of this biosimilar filgrastim and the patient population receiving it at home h...

Descripción completa

Detalles Bibliográficos
Autores principales: Otremba, Burkhard, Hielscher, Carsten, Petersen, Volker, Petrik, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199230/
https://www.ncbi.nlm.nih.gov/pubmed/30410313
http://dx.doi.org/10.2147/PPA.S168029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199230/
https://www.ncbi.nlm.nih.gov/pubmed/30410313
http://dx.doi.org/10.2147/PPA.S168029

Ejemplares similares